Egan-Jones Ratings Company Welcomes Dr. Sylvain Raynes to Lead Structured Finance Initiatives
In a significant move for the financial services industry, Egan-Jones Ratings Company has announced the appointment of Dr. Sylvain Raynes to the role of leader for its structured finance segment. Dr. Raynes brings over three decades of expertise in structured finance, credit risk evaluation, and transaction structuring to Egan-Jones. His rich career includes advising a diverse range of global clients, from investors and financial institutions to regulatory agencies, on complex securitizations across various asset classes, such as asset-backed securities, collateralized loan obligations, and both commercial and residential mortgage-backed securities.
Dr. Raynes is well-known within the finance community for his innovative contributions to structured finance analytics. He was a driving force in the co-development of cutting-edge systems such as Waterfall Editor and ABSTRAK, which are used in real-time valuation efforts in both primary and secondary markets. These methodologies are now a staple for leading market players and have earned recognition in prominent industry literature.
Sean Egan, the CEO and founding figure of Egan-Jones Ratings Company, expressed his enthusiasm for Dr. Raynes' arrival: "Sylvain brings a rare combination of technical depth, market experience, and analytical discipline. As structured finance markets continue to grow in scale and complexity, investors require independent, transparent analysis. His leadership strengthens our ability to meet that need and expand our capabilities in this important segment of the credit markets."
Throughout his illustrious career, Dr. Raynes has held key positions at renowned firms such as Moody's Investors Service, Credit Suisse First Boston, Goldman Sachs, Citibank, and PaineWebber (now part of UBS). He has also contributed his expertise in high-stakes litigation regarding structured finance and credit ratings, often serving as a testifying and consulting expert.
In his own words, Dr. Raynes articulated his commitment to quality analysis: "Investors deserve analysis they can trust, and that's what has always driven my work. I look forward to leading Egan-Jones' structured finance practice and supporting clients navigating increasingly complex credit environments with the transparent, investor-focused analysis this market demands."
This high-profile appointment underscores Egan-Jones' ongoing commitment to enhancing its analytical coverage and solidifying its stance as an adroit, independent credit rating provider. By adopting an investor-pay model, the firm aims to minimize conflicts of interest while promoting objective and high-quality analysis.
Notably, Dr. Raynes holds a doctorate in mechanical and aerospace engineering from the prestigious Princeton University. Egan-Jones Ratings Company, founded in 1995, is designated as a Nationally Recognized Statistical Rating Organization (NRSRO) and is dedicated to offering timely and accurate credit ratings along with proxy services.
The hiring of Dr. Raynes marks an exciting chapter for Egan-Jones Ratings Company as it strengthens its structured finance division, ultimately benefiting a wide array of stakeholders looking for trustworthy financial assessments in a complex environment.
Dr. Raynes is well-known within the finance community for his innovative contributions to structured finance analytics. He was a driving force in the co-development of cutting-edge systems such as Waterfall Editor and ABSTRAK, which are used in real-time valuation efforts in both primary and secondary markets. These methodologies are now a staple for leading market players and have earned recognition in prominent industry literature.
Sean Egan, the CEO and founding figure of Egan-Jones Ratings Company, expressed his enthusiasm for Dr. Raynes' arrival: "Sylvain brings a rare combination of technical depth, market experience, and analytical discipline. As structured finance markets continue to grow in scale and complexity, investors require independent, transparent analysis. His leadership strengthens our ability to meet that need and expand our capabilities in this important segment of the credit markets."
Throughout his illustrious career, Dr. Raynes has held key positions at renowned firms such as Moody's Investors Service, Credit Suisse First Boston, Goldman Sachs, Citibank, and PaineWebber (now part of UBS). He has also contributed his expertise in high-stakes litigation regarding structured finance and credit ratings, often serving as a testifying and consulting expert.
In his own words, Dr. Raynes articulated his commitment to quality analysis: "Investors deserve analysis they can trust, and that's what has always driven my work. I look forward to leading Egan-Jones' structured finance practice and supporting clients navigating increasingly complex credit environments with the transparent, investor-focused analysis this market demands."
This high-profile appointment underscores Egan-Jones' ongoing commitment to enhancing its analytical coverage and solidifying its stance as an adroit, independent credit rating provider. By adopting an investor-pay model, the firm aims to minimize conflicts of interest while promoting objective and high-quality analysis.
Notably, Dr. Raynes holds a doctorate in mechanical and aerospace engineering from the prestigious Princeton University. Egan-Jones Ratings Company, founded in 1995, is designated as a Nationally Recognized Statistical Rating Organization (NRSRO) and is dedicated to offering timely and accurate credit ratings along with proxy services.
The hiring of Dr. Raynes marks an exciting chapter for Egan-Jones Ratings Company as it strengthens its structured finance division, ultimately benefiting a wide array of stakeholders looking for trustworthy financial assessments in a complex environment.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.